| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
CBDB manufacturers
- CBDB
-
- $7.00
-
2025-03-21
- CAS:60113-11-3
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1000KGS
|
| Product Name: | CBDB | | Synonyms: | CBDB;Cannabidiol C4;CBDB (CRM);1,3-Benzenediol, 5-butyl-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-, (1R-trans)- (9CI);(1R-trans)-5-butyl-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol;Cannabidibutol | | CAS: | 60113-11-3 | | MF: | C20H28O2 | | MW: | 300.44 | | EINECS: | | | Product Categories: | | | Mol File: | 60113-11-3.mol |  |
| Boiling point | 451.7±45.0 °C(Predicted) | | density | 1.035±0.06 g/cm3(Predicted) | | solubility | DMF: 50 mg/ml DMSO: 60 mg/ml DMSO: PBS (pH 7.2) (1:3): 0.25 mg/ml Ethanol: 35 mg/ml | | pka | 9.61±0.45(Predicted) | | InChI | InChI=1/C20H28O2/c1-5-6-7-15-11-18(21)20(19(22)12-15)17-10-14(4)8-9-16(17)13(2)3/h10-12,16-17,21-22H,2,5-9H2,1,3-4H3/t16-,17+/s3 | | InChIKey | WBRXESQKGXYDOL-XGTFWIOGNA-N | | SMILES | C([C@@H]1CCC(C)=C[C@H]1C1C(=CC(CCCC)=CC=1O)O)(=C)C |&1:1,7,r| |
| WGK Germany | WGK 2 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 4 Dermal Acute Tox. 4 Inhalation Acute Tox. 4 Oral Eye Irrit. 2 Flam. Liq. 2 |
| Description | CBDB (CRM) (Item No. 32719) is a certified reference material categorized as a phytocannabinoid.1 CBDB has been found in strains of Cannabis and hemp.1,2 CBDB is considered an impurity in commercial extractions of cannabidiol (CBD) from hemp.2 This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | References | [1] PASQUALE LINCIANO. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol[J]. Journal of Natural Products , 2019, 83 1: 88-98. DOI: 10.1021/acs.jnatprod.9b00876 [2] CINZIA CITTI . Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog[J]. Journal of pharmaceutical and biomedical analysis, 2019, 175: Article 112752. DOI: 10.1016/j.jpba.2019.06.049 |
| | CBDB Preparation Products And Raw materials |
|